Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

clinical trialsClinicalTrials.govT1Dtrial matching

What this is and is not

This is a discovery layer for official trial records. It is not an eligibility decision, treatment recommendation, or invitation to share private health information.

A useful trial watch should help a family ask better questions: Who is eligible? What is the intervention? Where is the site? What is the burden? What endpoints are being measured?

Recruiting records to inspect

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes — RECRUITING, PHASE2. Interventions: High Dose SAB-142, Low Dose SAB-142, Placebo. Locations: San Francisco, California, United States | San Jose, California, United States | Aurora, Colorado, United States. This is a Pha...Source
A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity — RECRUITING, PHASE1. Interventions: Tirzepatide, Acetaminophen, Placebo. Locations: Miami, Florida, United States. The main purpose of this study is to learn more how tirzepatide affects stomach emptying in participants...Source
Basic Hematological Parameters and Coagulation Profile in Type 1 Diabetic Children — RECRUITING. Locations: Asyut, Asyut Governorate, Egypt. Diabetes mellitus is a group of chronic metabolic diseases characterized by hyperglycemia .Type 1 diabetes is a heterogeneous disease related to the destruction of...Source
Genetic Risk Score of Type 1 Diabetes Mellitus for Progression to Insulin in Diabetic Patients Lack of Predictive Value: a Multicenter Nested Case-control Study — RECRUITING. Locations: Changsha, Hunan, China. The goal of this observational study is to evaluate the predictive value of the genetic risk score for type 1 diabetes in the progression to insulin deficiency in diabetic...Source
Allogeneic Anti-CD7 CAR-T for Type 1 Diabetes — RECRUITING, EARLY_PHASE1. Interventions: Allogeneic CD7-Targeted CAR-T Cell Injection. Locations: Shanghai, China. Type 1 diabetes mellitus (T1DM) is a T cell-mediated autoimmune disease characterized by autoimmune dest...Source
Intervention for Children With Type 1 Diabetes Targeting Gut Microbes — RECRUITING, NA. Interventions: Trimtab. Locations: Shanghai, Shanghai Municipality, China. The goal of this clinical study is to evaluate the effect of nutritional intervention program based on dietary products in the c...Source
Precision Administration of Anti-thymocyte Globulin With or Without Verapamil — RECRUITING, PHASE2. Interventions: Anti-thymocyte globulin (ATG), verapamil extended release capsule, Placebo. Locations: Aurora, Colorado, United States | Gainesville, Florida, United States. T cell directed therapy, a...Source
Anti-viral Action Against Type 1 Diabetes Autoimmunity — RECRUITING, PHASE4. Interventions: Comirnaty Injectable Product, Sodium Chloride 0.9% Inj. Locations: Vienna, Austria | Leuven, Belgium | Munich, Bavaria, Germany. The study GPPAD-05 AVAnT1A is a phase 4 clinical trial...Source

Questions before contacting a study

Is the study specifically for Type 1 diabetes, and does it match the participant age, disease stage, and treatment context?
What travel, visit frequency, labs, devices, medication changes, and hypoglycemia risk are involved?
Can the family discuss the official record with their endocrinology team before sharing additional personal health details?

This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.